Gemeinnützige Krankenhausbetriebsgesellschaft Konstanz Mbh

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
AFAMOSI: Efficacy and Safety of Afatinib Followed by Osimertinib Compared to Osimertinib in Patients with EGFRmutated/T790M Mutation Negative Nonsquamous NSCLC	Non-squamous NSCLC	Active, not recruiting	Phase 4	2025-03-25		NCT04413201

Clinical trials